News

Chobani and La Colombe Unveil New Seasonal Flavor Delights

Chobani and La Colombe Unveil New Seasonal Flavor Delights

Celebrate the Season with New Flavors

This holiday season, Chobani and La Colombe have teamed up to make your celebrations a little brighter with their exciting new seasonal offerings. Fans of these brands are in for a treat as they introduce a limited-edition holiday portfolio that includes the delightful new Apple Pie Creamer, designed to bring that festive flavor straight to your morning coffee.

Delight in the Festive Flavors

The Apple Pie Dairy Coffee Creamer promises to deliver a warm and cozy experience, reminiscent of baking pies during holiday gatherings. Packaged from farm-fresh milk, it brings nostalgic flavors of warm apples and cinnamon. This exciting addition is available now at retailers nationwide for a suggested retail price of $5.59 per 24 fl oz bottle.

According to Chobani's recent consumer research, apple pie emerged as the most requested flavor for this season. Niel Sandfort, the Chief Innovation Officer at Chobani, expressed enthusiasm about offering unique flavors that resonate with consumers during winter months. He mentioned how seasonal options serve as a creative outlet for the company, allowing them to experiment with comforting, indulgent flavors that enhance the coffee experience.

Returning Fan-Favorites

In addition to the new Apple Pie Creamer, beloved seasonal flavors are returning to shelves, including:

Holiday Yogurts and Oatmilks

  • Chobani® Greek Yogurt Spiced Holiday Nog ($1.59): This yogurt is infused with warming spices, perfect for anyone looking to bake or mix into festive recipes.
  • Chobani® Flip® Peppermint Perfection ($1.79): Experience the joy of dark chocolate cookies combined with refreshing peppermint and vanilla Greek yogurt.
  • Chobani® Oatmilk Oat Nog ($4.29): This creamy drink made from gluten-free oats is a delicious addition to festive drinks and recipes.
  • Chobani® Peppermint Mocha Dairy Coffee Creamer ($5.59): A year-round favourite, this creamer combines rich chocolate and sweet mint flavors.
  • La Colombe® Peppermint Mocha Draft Latte® (starting at $3.29): Enjoy a frothy, cafe-quality mocha latte created with real cocoa.

Introducing Oat Nog Draft Latte

This year, all La Colombe cafes will feature the Oat Nog Draft Latte, introducing a blend of Chobani's Oat Nog with La Colombe's signature draft latte. This delightful drink can be tailored for lattes, cappuccinos, and mochas, ensuring that every guest can enjoy the season's flavors in their favorite beverage.

About Chobani

Founded by Hamdi Ulukaya, Chobani is committed to making high-quality, nutritious food accessible to everyone. Known particularly for its Greek yogurt, Chobani prides itself on using natural ingredients and avoiding artificial preservatives. Following the acquisition of La Colombe, they have expanded their offerings to include cold-pressed espresso and ready-to-drink coffees available at various retail locations, continuing to innovate within the food and beverage space.

About La Colombe

La Colombe has been a leader in coffee roasting since 1994, emphasizing ethical sourcing and quality craftsmanship in every cup. As pioneers of the textured canned cold latte, they remain at the forefront of the specialty coffee movement, providing exceptional products that reflect their commitment to quality and community.

Frequently Asked Questions

What is the new seasonal flavor introduced by Chobani?

The new seasonal flavor is the Apple Pie Dairy Coffee Creamer, bringing festive flavors to morning coffee.

When can I find these seasonal products in stores?

These seasonal products are available now at retailers nationwide for this holiday season.

What other flavors are returning from last year?

Returning flavors include Holiday Nog, Peppermint Mocha, and various limited-time yogurt flavors.

Where can I enjoy the Oat Nog Draft Latte?

The Oat Nog Draft Latte is available at all La Colombe cafe locations this holiday season.

How can I learn more about Chobani and La Colombe products?

For detailed information and recipes, you can visit the respective websites of Chobani and La Colombe.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles